To undertake a quantitative overview of trials of topical capsaicin for the treatment of diabetic neuropathy, osteoarthritis, post-herpetic neuralgia, and psoriasis.
A systematic search of the literature using both computerized and manual methods for identifying clinical trials of capsaicin. The trials identified were abstracted for response data, which then were analysed using established meta-analytic methods for both fixed and random effects modelling.
The odds ratio of the response rate of subjects receiving topical capsaicin relative to that of subjects on placebo was used as the main outcome measure. The difference in the response rate was used as the response variable under the random effects model. When dropouts were mentioned and unambiguous assignment could not be made, the analysis was made on the basis of intention to treat.
Capsaicin cream give more pain relief to patients with diabetic neuropathy than placebo did. The odds ratio (OR) and corresponding 95% confidence interval (95% CI) in favour of capsaicin cream were OR=2.74 (95% CI=1.73, 4.32). Using a random effect model the rate difference (RD) in favour of capsaicin cream was RD=0.25 (95% CI=0.15, 0.35).
Capsaicin cream was also better than placebo in providing pain relief in osteoarthritis: OR=4.36 (95% CI=2.77, 6.88) and RD=0.29 (95% CI=0.20, 0.37) and in psoriasis: OR=2.80 (95% CI=1.69, 4.62) and RD=0.35 (95% CI=0.14, 0.56). There was, however, evidence of heterogeneity in the individual RDs in psoriasis, and complete blinding was difficulty because of the initial discomfort associated with topical capsaicin.
In post-herpetic neuralgia the results were even less convincing.
Topical capsaicin appears to be effective in the management of a variety of painful clinical conditions affecting the skin. However, totally blind trials are difficult to conduct with this substance. Future trials will need to address this problem more rigorously if a definitive answer about the effectiveness of capsaicin is to be obtained.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Bernstein JE (1987) Capsaicin in the treatment of dermatologic disease. Cutis 39: 352–353
Council of Pharmaceutical Society of Great Britain (1952) Martindale — The Extra Pharmacopoeia 23 rd edn, vol 1. Pharmaceutical Press, London, pp 324
Li Wan Po A (1990) Non prescription drugs, 2nd edn. Blackwell, Oxford
Virus RM, Gebhart GF (1979) Pharmacologic actions of capsaicin: apparent involvement of substance P and serotonin. Life Sci 25: 1273–1284
Vaught JL (1988) Substance P antagonists and analgesia: a review of the hypothesis. Life Sci 43: 1419–1431
Payan P (1989) Neuropeptides and inflammation. The role of substance P. Ann Rev Med 40: 341–352
Nicoll RA, Schenker C, Leeman SE (1980) Substance P as a transmitter candidate. Ann Rev Neurosci 3: 227–268
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719–748
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Contr Clin Trials 7: 177–188
Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Beta-blockade during and after myocardial infarction: an overview of the randomised trials. Prog Cardiovasc Dis 27: 335–371
Chad DA, Aronin N, Lundstrom R, McKeon P, Ross D, Molitch M, Schipper HM, Stall G, Dyess E, Tarsy D (1990) Does capsaicin relieve the pain of diabetic neuropathy. Pain 42: 387–388
Scheffler NM, Sheitel PL, Lipton MN (1991) Treatment of painful diabetic neuropathy with capsaicin 0.075%. J Am Pediatr Med Assoc 31: 288–293
The Capsaicin Study Group (1991) Treatment of painful diabetic neuropathy with topical capsaicin — a multicentre, double-blind, vehicle-control study. Arch Intern Med 151: 2225–2229
Tandan R, Lewis GA, Krusinski PB, Badger GB, Fries TJ (1992) Topical capsaicin in painful diabetic neuropathy — controlled study with long-term follow-up. Diab Care 15: 8–14
Ross DR, Varipapa RJ (1989) Treatment of painful diabetic neuropathy with topical capsaicin. New Engl J Med 321: 474–475
Pirart J (1978) Diabetic mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diab Care 1: 168–88, 252–263
Deal CL, Schnitzer TJ, Lipstein E, Seibold JR, Stevens RM, Levy MD, Albert D, Renold F (1991) Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther 13: 383–393
McCarthy GM, McCarty DL (1992) Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J Rheumatol 19: 604–607
Schinitzer TJ, Morton C, Coker S, Flynn P (1992) Effectiveness of reduced applications of topical capsaicin (0.025%) in osteoarthritis. Arthritis and Rheumatism 35: S132
Harris ED (1990) Rheumatoid arthritis: pathophysiology and implications for therapy. New Engl J Med 322: 1277–1289
Lotz M, Carson DA, Vaughan JH (1987) Substance P activation of rheumatoid synoviocytes: neural pathogenesis of arthritis. Science 235: 893–895
Levine JD, Clark R, Devor M, Helms C, Moskowitz MA, Basbaum AI (1984) Intraneuronal substance P contributes to the severity of experimental arthritis. Science 226: 547–549
Badlamente MA, Cherney SA (1989) Periosteal and vascular innervation of the human patella in degenerative joints disease. Sem Arthr Rheum 18: 61–66
Fitzgerald M (1983) Capsaicin and sensory neurons — a review. Pain 15: 109–130
Bernstein JE, Korman NJ, Bickers DR, Dahl MV, Milliken LE (1989) Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol 21: 265–270
Drake HF, Harris AJ, Gamester RE, Justins D (1990) Randomised double-blind study of topical capsaicin for treatment of postherpetic neuralgia. Pain 5 [Suppl]: S58
Watson CPN, Evans RJ, Watt VR (1988) Postherpetic neuralgia and topical capsaicin. Can J Neurol Sci 15: 197
Peikert A, Hentrich M, Ochs G (1991) Topical 0.025% capsaicin in chronic postherpetic neuralgia: efficacy, predictors of response and long-term course. J Neurol 238: 452–456
Bernstein JE, Bickers DR, Dahl MV, Roshal JY (1987) Treatment of chronic postherpetic neuralgia with topical capsaicin — a preliminary study. J Am Acad Dermatol 17: 93–96
Fusco BM, Alessandri M (1992) Analgesic effect of capsaicin in idiopathic trigeminal neuralgia. Anesth Analg 74: 375–377
Hawk RJ, Millikan LE (1988) Treatment of oral postherpetic neuralgia with topical capsaicin. Int J Dermatol 27 (5): 336
Bucci FA, Gabriels CF, Krohel GB (1988) Successful treatment of postherpetic neuralgia with capsaicin. Am J Ophthalmol 106: 758–759
Don PC (1988) Topical capsaicin for treatment of neuralgia associated with Herpes zoster infection. J Am Acad Dermatol 18: 135
Jolleys JV (1989) Treatment of shingles and postherpetic neuralgia. Br Med J 298: 1537–1538
Arner A, Meyerson BA (1988) Lack of analgesic effect of opiods on neuropathic and idiopathic forms of pain. Pain 33: 11–23
Bernstein JE, Parish LC, Rapaport M, Rosenbaum MM, Roenigk HH (1986) Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J Am Acad Dermatol 15: 504–507
Kurkcuoglu N, Alaybeyi F (1990) Topical capsaicin for psoriasis. Br J Dermatol 123: 549–550
Berberian B, Bernstein JE, Dodd WA, Ellis CN, Rumsfield J, Sulica VI (1990) Double-blind evaluation of capsaicin cream in pruritis psoriasis. Clin Res 38: 664 A
Ellis CN, Berberian B, Sulien VI, Dodd WA, Jarratt MT, Katz HI, Prawer S, Krueger G, Rex IH Jr, Wolf JE (1993) A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol 29: 438–442
Naukkarinen A, Nickoloff BJ, Faber EM (1989) Quantification of cutaneous sensory nerves and their substance P content in psoriasis. J Invest Dermatol 92: 126–129
Anand P, Springall DR, Blank MA, Sellu D, Polack JM, Bloom SR (1992) Neuropeptides in skin disease: increased VIP in eczema and psoriasis but not axillary hyperhidrosis. Br J Dermatol 124: 547–549
Granek I, Ashikari P, Foley KM (1984) The postmastectomy pain syndrome: clinical and anatomical correlations. Proc ASCO 3: 122
Assa J (1974) The intercostobrachial nerve in radical mastectomy. J Surg Oncol 6: 123–26
Watson CPN, Evans RJ (1992) The postmastectomy pain syndrome and topical capsaicin: a randomized trial. Pain 51: 375–379
Watson CPN, Evans RJ, Watt UR (1989) The post-mastactomy pain syndrome and the effect of topical capsaicin. Pain 38: 177–186
Dini D, Bertelli G, Gozza A, Forno GG (1993) Treatment of the post-mastactomy pain syndrome with topical capsaicin. Pain 54: 223–226
Rayner HC, Atkins RC, Westerman RA (1989) Relief of local stump pain by capsaicin cream. Lancet II: 1276–1277
Weintraub M, Golik A, Rubio A (1990) Capsaicin for treatment of post-traumatic amputation stump pain. Lancet 336: 1003–1004
About this article
Cite this article
Zhang, W.Y., Li Wan Po, A. The effectiveness of topically applied capsaicin. Eur J Clin Pharmacol 46, 517–522 (1994). https://doi.org/10.1007/BF00196108
- Diabetic neuropathy
- pain relief